Coronavirus vaccine could get emergency approval before critical testing is complete, FDA says
5 years ago 1 min read
The head of the U.S. Food and Drug Administration says that coronavirus vaccines may be given emergency approval before rigorous clinical trials are complete.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push